{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:28:56Z","timestamp":1782210536277,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017030","name":"Worcester Polytechnic Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.dmd.2025.100173","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:37:15Z","timestamp":1758760635000},"page":"100173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alcohol dehydrogenase 4 and aldo-keto reductase 1A1 catalyze the oxidation of 4-hydroxytolbutamide, a metabolite of tolbutamide, in the human liver"],"prefix":"10.1016","volume":"53","author":[{"given":"Kazuya","family":"Shimomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-8828","authenticated-orcid":false,"given":"Shotaro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7696-5814","authenticated-orcid":false,"given":"Nao","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9884-2768","authenticated-orcid":false,"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-2454","authenticated-orcid":false,"given":"Hiroshi","family":"Suemizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dmd.2025.100173_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-9556(24)15367-6","article-title":"Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes","volume":"28","author":"Chen","year":"2000","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2025.100173_bib2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/dmd.118.081182","article-title":"Differences in the in vivo and in vitro metabolism of imrecoxib in humans: formation of the rate-limiting aldehyde intermediate","volume":"46","author":"Hou","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100173_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100173_bib4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/dmd.110.037259","article-title":"CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay","volume":"39","author":"Iwamura","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2025.100173_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1124\/dmd.107.018234","article-title":"Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys","volume":"36","author":"Christopher","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100173_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.trsl.2011.07.002","article-title":"Acyclovir-induced nephrotoxicity: the role of the acyclovir aldehyde metabolite","volume":"158","author":"Gunness","year":"2011","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.dmd.2025.100173_bib7","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001917","article-title":"Characterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone","volume":"53","author":"Sato","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2025.100173_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bdd.1893","article-title":"Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats","volume":"35","author":"Choi","year":"2014","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2025.100173_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","article-title":"The role of alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation","volume":"23","author":"Di","year":"2021","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.dmd.2025.100173_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/jm00322a014","article-title":"The metabolic fate of tolbutamide in man and in the rat","volume":"9","author":"Thomas","year":"1966","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.dmd.2025.100173_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2125.1998.00721.x","article-title":"Cytochrome P4502C9: an enzyme of major importance in human drug metabolism","volume":"45","author":"Miners","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100173_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498254.2021.1875515","article-title":"Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes","volume":"51","author":"Uehara","year":"2021","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.dmd.2025.100173_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(25)28256-8","article-title":"The metabolism of tolbutamide in rat liver","volume":"167","author":"McDaniel","year":"1969","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.dmd.2025.100173_bib14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/molecules25081937","article-title":"Metabolic-hydroxy and carboxy functionalization of alkyl moieties in drug molecules: prediction of structure influence and pharmacologic activity","volume":"25","author":"El-Haj","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.dmd.2025.100173_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/dmd.122.001198","article-title":"Development and validation of a proteomic correlation profiling technique to detect and identify enzymes involved in metabolism of drugs of concern","volume":"51","author":"Kudo","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100173_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.dmd.2025.100173_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152648","article-title":"Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid","volume":"448","author":"Ogiso","year":"2021","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.dmd.2025.100173_bib18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100173_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109536","article-title":"Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism","volume":"736","author":"Ichida","year":"2023","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.dmd.2025.100173_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2023.04.054","article-title":"HepaSH cells: experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes","volume":"663","author":"Uehara","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.dmd.2025.100173_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100057","article-title":"Switch\/sucrose non-fermentable complex interacts with constitutive androstane receptor to regulate drug-metabolizing enzymes and transporters in the liver","volume":"53","author":"Kurosawa","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2025.100173_bib22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acs.chemrestox.5b00129","article-title":"Comparison of the reactivity of trapping reagents toward electrophiles: cysteine derivatives can be bifunctional trapping reagents","volume":"28","author":"Inoue","year":"2015","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100173_bib23","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0090-9556(24)15085-4","article-title":"Formation of a dihydroxy metabolite of phenytoin in human liver microsomes\/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4","volume":"28","author":"Komatsu","year":"2000","journal-title":"Drug Metab Dispos"},{"issue":"36","key":"10.1016\/j.dmd.2025.100173_bib24","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1021\/bi980611s","article-title":"Oxidative decarboxylation of 6-phosphogluconate by 6-phosphogluconate dehydrogenase proceeds by a stepwise mechanism with NADP and APADP as oxidants","volume":"37","author":"Hwang","year":"1998","journal-title":"Biochemistry"},{"issue":"Pt 2","key":"10.1016\/j.dmd.2025.100173_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/bj3430487","article-title":"Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members","volume":"343","author":"O\u2019connor","year":"1999","journal-title":"Biochem J"},{"issue":"8","key":"10.1016\/j.dmd.2025.100173_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/hep4.1530","article-title":"Nicotinamide adenine dinucleotide metabolome is functionally depressed in patients undergoing liver transplantation for alcohol-related liver disease","volume":"4","author":"Parker","year":"2020","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.dmd.2025.100173_bib27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2015.11.018","article-title":"Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases","volume":"64","author":"Ghallab","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dmd.2025.100173_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol Res"},{"issue":"12_suppl","key":"10.1016\/j.dmd.2025.100173_bib29","doi-asserted-by":"crossref","first-page":"S666","DOI":"10.1177\/09603271211052991","article-title":"NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice","volume":"40","author":"Xu","year":"2021","journal-title":"Hum Exp Toxicol"},{"issue":"12","key":"10.1016\/j.dmd.2025.100173_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1080\/00498254.2021.2007553","article-title":"Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver","volume":"51","author":"Zhang","year":"2021","journal-title":"Xenobiotica"},{"issue":"1\u20133","key":"10.1016\/j.dmd.2025.100173_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2010.12.005","article-title":"Oxidation of methanol, ethylene glycol, and isopropanol with human alcohol dehydrogenases and the inhibition by ethanol and 4-methylpyrazole","volume":"191","author":"Lee","year":"2011","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.dmd.2025.100173_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/dmd.122.001037","article-title":"Quantitative evaluation of the contribution of each aldo-keto reductase and short-chain dehydrogenase\/reductase isoform to reduction reactions of compounds containing a ketone group in the human liver","volume":"51","author":"Ichida","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100173_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2012.00035","article-title":"Regulation of aldo-keto reductases in human diseases","volume":"3","author":"Chen","year":"2012","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.dmd.2025.100173_bib34","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.biochi.2012.07.013","article-title":"DNA methylation dynamics in the hepatic CYP3A4 gene promoter","volume":"94","author":"Kacevska","year":"2012","journal-title":"Biochimie"},{"issue":"11\u201312","key":"10.1016\/j.dmd.2025.100173_bib35","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/10715762.2020.1761547","article-title":"The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity of human hepatoma cells","volume":"54","author":"Ong","year":"2020","journal-title":"Free Radic Res"},{"issue":"6","key":"10.1016\/j.dmd.2025.100173_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.dmpk.2020.08.004","article-title":"Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase\/reductase isoforms in human livers","volume":"35","author":"Amai","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.dmd.2025.100173_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.abb.2007.04.024","article-title":"Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms","volume":"464","author":"Penning","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.dmd.2025.100173_bib38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1046\/j.1471-4159.2003.01628.x","article-title":"Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex","volume":"84","author":"Murphy","year":"2003","journal-title":"J Neurochem"},{"issue":"36","key":"10.1016\/j.dmd.2025.100173_bib39","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.1021\/bi010872t","article-title":"The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation","volume":"40","author":"Palackal","year":"2001","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.dmd.2025.100173_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmd.2025.100173_bib41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-pharmtox-052220-104025","article-title":"Targeting NRF2 and its downstream processes: opportunities and challenges","volume":"62","author":"Torrente","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100173_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxlet.2012.12.026","article-title":"Identification of aldo-keto reductases as NRF2-target marker genes in human cells","volume":"218","author":"Jung","year":"2013","journal-title":"Toxicol Lett"},{"issue":"7","key":"10.1016\/j.dmd.2025.100173_bib43","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/tx400041v","article-title":"Oxidative bioactivation of abacavir in subcellular fractions of human antigen presenting cells","volume":"26","author":"Bell","year":"2013","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100173_bib44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/jm00206a002","article-title":"Metabolic fate of tolazamide in man and in the rat","volume":"21","author":"Thomas","year":"1978","journal-title":"J Med Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:56:24Z","timestamp":1763754984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625094826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0090955625094826"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100173","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol dehydrogenase 4 and aldo-keto reductase 1A1 catalyze the oxidation of 4-hydroxytolbutamide, a metabolite of tolbutamide, in the human liver","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100173"}}